Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.53 -0.82 (-5.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cullinan Therapeutics (CGEM) Long-Term Investments (2021 - 2026)

Updated

Cullinan Therapeutics' Long-Term Investments came in at $19.02 million for Q2 2026, down 92.2% from $242.3 million a year earlier and down 50.6% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Long-Term Investments (2021 - 2026) Analysis & Trends

At the end of FY2025, Cullinan Therapeutics' Long-Term Investments was $58.27 million, down 71.5% from FY2024.

  • Long-Term Investments carries a four-year compound annual growth rate of -19.7% (FY2021 to FY2025).
  • Going back by year, Long-Term Investments was $204.44 million in FY2024, $80.88 million in FY2022 (-42.4%) and $140.4 million in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Long-Term Investments since Q3 2023.
  • Year-over-year, Long-Term Investments has declined for three consecutive quarters, with growth averaging 33.3% over the last five quarters.
  • The fastest year-over-year change in Long-Term Investments over five years came in Q3 2024 (growth of 274.0%), and the weakest in Q2 2026 (a decline of 92.2%).
  • Business Quant data shows CGEM's Long-Term Investments at $38.5 million (Q1 2026), $58.27 million (Q4 2025) and $140 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - 19.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.02 Mn
Mar 31, 2026 38.50 Mn
Dec 31, 2025 58.27 Mn
Sep 30, 2025 140.00 Mn
Jun 30, 2025 242.30 Mn
Mar 31, 2025 259.39 Mn
Dec 31, 2024 204.44 Mn
Sep 30, 2024 57.98 Mn
Sep 30, 2023 15.50 Mn
Jun 30, 2023 20.30 Mn
Mar 31, 2023 112.80 Mn
Dec 31, 2022 80.88 Mn
Sep 30, 2022 30.70 Mn
Jun 30, 2022 44.60 Mn
Mar 31, 2022 95.40 Mn
Dec 31, 2021 140.40 Mn
Sep 30, 2021 124.33 Mn
Jun 30, 2021 119.64 Mn
Mar 31, 2021 32.11 Mn
API Access

Cullinan Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CGEM&period=max&api_key=YOUR_API_KEY